{"database": "openregs", "table": "documents", "rows": [["FDA-2026-D-2839-0001", "FDA", "FDA-2026-D-2839", "Oncology Pharmaceuticals: Streamlined Nonclinical Safety Studies for Biologics and Conjugated Products; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2026-06-01T04:00:00Z", 2026, 6, "2026-06-01T04:00:00Z", null, "2026-06-01T17:32:10Z", "2026-10873", 0, 0, "09000064b9303ad2"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-D-2839-0001"], "units": {}, "query_ms": 0.18321399693377316, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}